Professor of Clinical Medicine and Associate Chief, Division of Medical Oncology, UCSF
| CONTACT | |
|
(415) 353-9888 (appts) Box 1705, UCSF; San Francisco, CA 94143-1705 |
additional websites: |
| EDUCATION | |
|
Rutgers College, New Brunswick, New Jersey, BA, 1976, Biological Sciences
|
|
| PROFESSIONAL EXPERIENCE | |
|
1977 |
Instructor of Medicine |
|
1981 |
Assistant Clinical Professor of Medicine |
|
1997-present |
Director, Clinical Research Office, UCSF/Mt. Zion Cancer Center |
|
1994-2000 |
Associate Professor of Clinical Medicine |
|
2000-present |
Professor of Clinical Medicine |
|
2003-present |
Associate Chief, Division of Medical Oncology |
| HONORS & AWARDS | |
|
1999 |
Mention-Colon Cancer-Medical Oncologist, Top Cancer Specialsts, Good Housekeeping |
|
1999 |
Mention-Medical Oncology and Hematology, Top 425 Doctors in the Bay Area, San Francisco |
| SELECTED PUBLICATIONS | |
|
Venook AP and Warren RS: Regional chemotherapy approaches for primary and metastatic liver tumors. Surg Onc Clin No Amer 5:411-427,1996. | |
|
Venook AP, Goodnight J, Kumar S, Taylor C, Gilden R, Figlin RA: Practice guidelines for colorectal cancer. Cancer J Sci Am 2 (supplement): S23-S36, 1996. | |
|
Venook AP, Goodnight J, Smith NG, Taylor C, Gilden R, Figlin RA: Practice guidelines for gastric cancer. Cancer J Sci Am 2 (supplement): S45-S52, 1996. | |
|
Goodnight J, Venook AP, Ames M, Taylor C, Gilden R, Figlin RA: Practice guidelines for esophageal cancer. Cancer J Sci Am 2 (supplement): S37-S43, 1996. | |
|
Goodnight J, Venook AP, Fringer J, Taylor C, Gilden R, Figlin RA: Practice guidelines for pancreatic cancer. Cancer J Sci Am 2 (supplement): S53-S60, 1996. | |
|
Venook AP, Eaton V, Chang J, Frey J, Ring E, Stagg RJ: Chemoembolization for liver metastases from uveal melanoma. GI Cancer 1: 269-273, 1996. | |
|
Dorsey BV, Benjamin LE, Rauscher F, Klencke B, Venook AP, Warren RS, Weidner N: Intra-abdominal desmoplastic small round-cell tumor: expansion of the pathologic profile. Mod Pathol 9: 703-709, 1996. | |
|
Kirn D, Venook AP, Penn I: Pulmonary aspergillosis masquerading as progressive post-transplant lymphoma. Transpl Int 9: 517-519, 1996. | |
|
Venook AP: Can a vitamin prevent hepatocellular carcinoma? Hepatology 22: 249-250, 1997. | |
|
Venook AP: Update on hepatic intra-arterial chemotherapy. Oncology 11: 947-957, 1997. | |
|
Venook AP: Treatment of hepatocellular carcinoma: a review of selected significant papers since 1995. Medscape Oncology 1 (12), 1997. | |
|
Venook AP, Egorin MJ, Rosner GL, Brown TD, Jahan TM, Batist G, Hohl R, Budman D, Ratain MJ, Kearns CM, Schilsky RL: A phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: CALGB 9264. J Clin Oncol 16: 1811-1819, 1998. | |
|
Floren LC, Hebert MF, Venook AP, Jordan VC, Cisneros A, Somberg KA: Tamoxifen in liver disease: potential exacerbation of hepatic dysfunction. Ann Oncol 9: 1123-1126, 1998. | |
|
Venook AP: Embolization and chemoembolization therapy for neuroendocrine tumors. Current Opinion in Oncology 11: 38-41, 1999. | |
|
Rubin J, Ajani J, Schirmer W, Venook AP, Bukowski R, Pommier R, Saltz L, Dandona P, Anthony L: Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J Clin Oncol 17: 600-606, 1999. | |
|
Venook AP, Egorin MJ, Rosner GL, Brown TD, Jahan TM, Batist G, Hohl R, Budman D, Ratain MJ, Kearns CM, Schilsky RL: Trial of Paclitaxel in Patients with Hepatic Dysfunction; Cancer and Leukemia Group B 9264. J Clin Oncol-Classic Papers and Current Comments 4;1: 185-194, 1999. | |
|
Bloom AI, Gordon RL, Ahl KH, Kerlan RK Jr, LaBerger JM, Wilson MW, Venook AP, Warren RS: Transcatheter embolization for the treatment of misperfusion after hepatic artery chemoinfusion pump implantation. Ann Surg Onc 6(4): 350-358. | |
|
Venook AP: Regional strategies for managing hepatocellular carcinoma. Oncology 14(3): 347-354, 2000. | |
|
Venook AP, Egorin MJ, Rosner GL, Holis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ: A phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: CALGB 9565. J Clin Oncolo 18: 2780-2787, 2000. | |
|
Bergsland EK, Venook AP: hepatocellular carcinoma. Curr Opin Oncol 12: 357-361, 2000. | |
|
Venook AP: Hepatocellular Carcinoma. Curr Treatment Options in Oncol 1:407-414, 2000. | |
|
Venook AP, Warren RS: Therapeutic approaches to metastasis confined to the liver. Curr Oncol Rep 3: 109-115, 2001. | |
|
Yao FY Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook AP, Ascher NL, Roberts JP: Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Soize Limits Does Not Adversely Impact Survival. Hepatology 33(6): 1394-1403, 2001. |
|
|
12/15/04 |
|


